Dr. Arvinder Singh Soin

• MT India Healthcare Award - 2016
• MSOSA Award for Excellence - 2014
• Doc n Doc Award for Excellence in Liver Transplantation - 2014
• DMA Distinguished Services Award - 2013
• E- medinews award - 2012
• RD Birla - 2011
• Swastha Bharat Samman - 2011
• Padma Shri by the President of India - 2010
• Achievements listed in Limca Book of Records - 2010
• Achievements listed in Limca Book of Records - 2009
• Achievements listed in Limca Book of Records - 2008
• Medindia Oration and Medindia Award - 2008
• Listed in Limca Book of Records - 2007
• Awarded British Transplantation Society Bursary - 1997
• Awarded research grant - 1996
• Awarded British Transplantation Society Bursary - 1994
• DMA Award - 1990

• Association of Surgeons of India
• British Transplantation Society
• The Royal College of Surgeons of Edinburgh (RCSED)
• Royal College of Physicians and Surgeons of Glasgow (RCPSG)
• Indian Society of Organ Transplantation (ISOT)
• Indian Society of Gastroenterology
• Indian Association of Surgical Gastroenterology
• Indian Society of Nephrology (ISN)
• Asian Society of Organ Transplantation International Society of Liver Transplantation

Dr. Arvinder Singh Soin has published over 183 papers, some of which are mentioned below:

• Prevalence of Modifiable Risk Factors for de novo Malignancies After Living Donor Liver Transplantation, 2024
• CMV duodenitis causing persistent hypoalbuminemia and ascites after liver transplantation, 2024
• Hilar Anatomy in 3035 Living Liver Donors: A Novel Classification for Donor Surgery and Suitability, Hepatic Surgeries, and Hepatobiliary Interventions, 2023
•  Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians, 2023
• Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition? 2023
• 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations, 2023
• Atezolizumab and Bevacizumab for Treatment of Patients With Unresectable / Non-transplantable Advanced Hepatocellular Carcinoma: A Real-World Single Center Experience from North India, 2023
• Postoperative Day 7 serum creatinine and serum bilirubin levels predict mortality in living donor liver transplantation recipients with early allograft dysfunction, 2023
• Safety and Efficacy of Dual PPAR- Alpha Agonist, Saroglitazar, in Management of NAFLD with Diabetes and/or Dyslipidemia in Liver Transplant Recipients, 2023
• Post-transplant non-alcoholic fatty liver disease and metabolic syndrome after living donor liver transplantation in Indians, 2023
• Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference, 2023
• Does the total robotic approach compromise recipient outcomes with liver graft with complex anatomy or extremes of weight compare to open right donor hepatectomy? 2023
• Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition? 2023
• National Liver Allocation Policy (N-LAP) - Consensus document by the Liver Transplantation Society of India for a nationally uniform system of allocation of deceased donor liver grafts, 2022
• Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis, influence suitability for and outcome after living donor liver transplantation? – A systematic review of the literature and expert panel recommendations, 2022
• Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant, 2021
• Articles Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19- associated cytokine release syndrome (COVINGTON): an open-label, multicentre, randomized, controlled, phase 3 trial, 2021
• Reply to Comment: A Worldwide Survey of Live Liver Donor Selection Policies at 24 Centers With a Combined Experience of 19 009 Adult Living Donor Liver Transplants, 2021
• Safety assessment of RhD-positive red cell transfusion in RhD-negative liver-transplant recipients: Single-centre report from India, 2020
• Liver Transplantation Society of India Guidelines for the Management of Acute Liver Injury Secondary to Yellow Phosphorus–Containing Rodenticide Poisoning Using the Modified Delphi Technique of Consensus Development, 2020
• Pediatric liver transplantation in severe hepatopulmonary syndrome and use of inhaled nitric oxide for post?transplant hypoxemia–a single center experience, 2020
• Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of Two Randomized Controlled Trials, 2020
• An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise, 2020
• Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative Effort, 2020
• Factors Associated With Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: Unanswered Questions, 2019
• Predictors of De Novo Non-alcoholic Fatty Liver Disease After Liver Transplantation: Many Unanswered Questions, 2019
• A Worldwide Survey of Live Liver Donor Selection Policies at 24 Centers With a Combined Experience of 19 009 Adult Living Donor Liver Transplants, 2018
• A Retrospective Comparative Study of Venous versus Non-Ringed Expanded Polytetrafluoroethylene (e-PTFE) Extension Grafts for Anterior Sector Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation, 2018
• Proposal for a Worldwide Usable Score for the Prediction of Recurrence and Intention-to-Treat Survival after Liver Transplantation in Patients with Hepatocellular Cancer: A West-East Analysis on 1,903 Patients, 2018
• Good Outcome of Living Donor Liver Transplantation for Severe Alcoholic Hepatitis not Responding to Medical Management: a Single Center Experience of 39 Patients, 2018
• 4. Outcome of living donor liver transplantation between genetically related and unrelated donors: experience of 1372 adult living donor liver transplantations from a single center, 2018
• Renal Function Outcomes with Everolimus Plus Reduced-Exposure Tacrolimus in de Novo Living Donor Liver Transplantation: 24-month results from the H2307 study,l 2018
• An Intention-to-Treat Competing-Risk Model for Candidates with Hepatocellular Cancer Awaiting Liver Transplantation, 2018
• Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study. 2017
• Survey Results of the Expert Meeting on Laparoscopic Living Donor Hepatectomy and Literature Review, 2017
• Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India, 2017
• Living Donor Liver Transplantation for Severe Alcoholic Hepatitis Not Responding to Medical Management: An Experience of 31 Patients, 2017
• High MELD score does not adversely affect the outcome of Living Donor Liver Transplantation: Experience in 1000 recipients, 2017
• Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy, 2017
• Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy, 2017
• (D+10) MELD as a Novel Predictor of Patient and graft Survival after Adult to Adult Living Donor Liver Transplantation, 2017
• Good outcome of living donor liver transplantation in drug-induced acute liver failure: A single-center experience, 2017
• Impact of endoscopic ultrasound-guided fine-needle aspiration in prospective liver transplant recipients with hepatocellular carcinoma and lymphadenopathy, 2016
• Impact and safety of endoscopic ultrasound-guided fine needle aspiration on patients with cirrhosis and pyrexia of unknown origin in India, 2016
• Innovative Approach of Using Esophageal Stent for Refractory Post-Band Ligation Esophageal Ulcer Bleed Following Living Donor Liver Transplantation, 2016
• Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation, 2015
• CMV Infection in Living Donor Liver Transplant Recipients Significantly Impacts the Early Post-Transplant Outcome: A Large Single Center Experience, 2015
• Everolimus with reduced tacrolimus versus standard tacrolimus in living-donor liver transplant recipients: Baseline data from the H2307 Study, 2015
• Sarcopenic Obesity With Metabolic Syndrome: A Newly Recognized Entity Following Living Donor Liver Transplantation, 2015
• Successful Donation After Rapid Reversal of Liver Steatosis with Life Style Modification in Highly Motivated Donors in Living Donor Liver Transplant Program, 2014
• Low Dose, Short Term HBIG with High Genetic Barrier Antivirals, Is Associated with Minimal Risk of Hepatitis B Recurrence after Liver Transplantation., 2013
• Smoothing the path: Reducing biliary complications, addressing small?for?size syndrome, and making other adaptations to decrease the risk for living donor liver transplant recipients, 2012
• Accuracy of T-2 Weighted Magnetic Resonance Cholangiopancreatography in Evaluation of Biliary Anatomy in Living Liver Donors, 2011
• Graft to Recipient Weight Ratio Analysis of 414 Consecutive Living Donor Liver Transplants: How Much Can the Bar Be Lowered?, 2010
• Twenty-Two Month Liver Recipient with Maple Syrup Urine Disease Donates Liver to Another Toddler: A Report on the World's Youngest Domino Pair, 2010
• End-stage non-alcoholic fatty liver disease: Evaluation of pathomorphological features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program, 2009
• Transabdominal gastroesophageal devascularization without transection for bleeding varices: Results and indicators of prognosis, 2007